Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)
Stopped early · Phase 4
Conditions studied: Renal Malignant Tumor
In brief
Patients with renal lesions suspicious for renal cell carcinoma (RCC) have a variety of different treatment pathways available to them. Imaging surveillance is being used frequently on smaller renal masses, and radiologists are being asked to biopsy more renal lesions to better guide decision making by urology. This is in large part due to the pathologic grade of renal masses having been shown to correlate with patient outcomes. The World Health Organization (WHO) or Fuhrman grade is the standard grading scale used by pathologists for RCC. The goal of this study will be to correlate contrast enhanced ultrasound findings with the pathologic grade of RCC. Specifically, the investigators hypothesize that tumors with different pathologic grades will show different patterns of qualitative enhancement, as well as different perfusion kinetics.
Key facts
- Study ID
- NCT03821376
- Run by
- Indiana University
- People needed
- 12
- Starts
- 2019-07-16
- Expected to finish
- 2021-09-21
- Last updated by the study team
- 2024-10-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Greater than or equal to 18 years of age
- Previously identified renal mass with radiology and clinical features consistent with RCC
- Clinical care plan includes partial or total nephrectomy
You may not qualify if…
- Less than 18 years of age
- Currently pregnant
- Renal mass with clinical care plan that does not include nephrectomy
- Renal mass suspected to be non RCC neoplasm by imaging and clinical data
- Renal mass unable to be visualized by grayscale ultrasound
- Known renal vein thrombosis
Where it is running
- Indiana University Hospital — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.